Nicole Borrenpohl, NP
Psychiatric/Mental Health · Jefferson City, MONPI 1235473380
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $3,900 of the $6,090 with a category attached, or 64.0%. Johnson & Johnson accounts for 85.5% of it on its own, with 11 other manufacturers making up the rest. Reporting peaked in 2021 at $5,531 and has fallen 95.5% since, to $246 in 2024. Among psychiatric/mental health clinicians in MO with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 56 payments — averaging $108.75 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$5K
- Neurocrine Biosciences, Inc.$308
- AbbVie$235
- Alkermes, Inc.$103
- Lundbeck LLC$71
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$50
- plus $120 from 6 others
What the payments were for
- Consulting fees$3,90064%
- Travel & lodging$1,36622%
- Food & beverage$82414%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 10 | $5,204 |
| Neurocrine Biosciences, Inc. | 13 | $308 |
| AbbVie | 15 | $235 |
| Alkermes, Inc. | 2 | $103 |
| Lundbeck LLC | 5 | $71 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 3 | $50 |
| Sunovion Pharmaceuticals Inc. | 2 | $29 |
| Teva Pharmaceuticals USA, Inc. | 2 | $27 |
| Otsuka America Pharmaceutical, Inc. | 1 | $18 |
| Vanda Pharmaceuticals Inc. | 1 | $18 |
| Adlon Therapeutics L.p. | 1 | $16 |
| Eisai Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SPRAVATO$5,061
How this compares
$6,090 in reported general payments places this provider in the 90th percentile of 565 psychiatric/mental health providers in Missouri.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| IngrezzaValbenazine Tosylate | 16 | $134,291 |
| Invega SustennaPaliperidone Palmitate | 35 | $92,052 |
| Abilify MaintenaAripiprazole | 16 | $45,355 |
| VraylarCariprazine Hcl | 21 | $32,636 |
| AristadaAripiprazole Lauroxil | 12 | $28,781 |
| RexultiBrexpiprazole | 13 | $28,680 |
| Wellbutrin XlBupropion Hcl | 11 | $27,478 |
| Paliperidone ErPaliperidone | 23 | $11,307 |
| TrintellixVortioxetine Hydrobromide | 13 | $10,404 |
| Desvenlafaxine Succinate ErDesvenlafaxine Succinate | 68 | $4,951 |
| Risperidone OdtRisperidone | 18 | $3,607 |
| Buspirone Hcl | 144 | $2,810 |
| Quetiapine Fumarate | 122 | $2,538 |
| Atomoxetine Hcl | 15 | $2,481 |
| Lurasidone Hcl | 38 | $2,045 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Neurocrine Biosciences, Inc.Ingrezza | $308 | $134,29116 claims |
| Johnson & JohnsonInvega Sustenna | $5,204 | $92,05235 claims |
| Otsuka America Pharmaceutical, Inc.Abilify Maintena, Rexulti | $18 | $74,03529 claims |
| AbbVieVraylar | $235 | $32,63621 claims |
| Alkermes, Inc.Aristada | $103 | $28,78112 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 565 psychiatric/mental health providers in Missouri.
Other psychiatric/mental health in Jefferson City
- Aldijana SacicSaint Louis$510K
- Erin DuvallSpringfield$275K
- Laurel OwensLees Summit$246K
- Julie WaterburySaint Louis$135K
- Emily WoukSpringfield$90K
- Kristerpher BrimberryPoplar Bluff$74K
- Matthew LindquistSt Louis$42K
- Stacy EmersonKennett$25K
- Jeffery DavisCreve Coeur$24K
- Kelsey KingsboroughMexico$18K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.